Neurocrine Biosciences reported $13.9M in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US $ 4490M 446M
Acadia Pharmaceuticals ACAD:US $ -113.06M 69.96M
Acorda Therapeutics ACOR:US $ -24.52M 3.96M
Agios Pharmaceuticals AGIO:US $ -94.77M 0.15M
ALKERMES ALKS:US $ -35.9M 36.78M
Alnylam Pharmaceuticals ALNY:US $ -240.34M 18.12M
Amgen AMGN:US $ 1476M 423M
Aptinyx Inc APTX:US $ -19827000 217K
Biogen BIIB:US $ 303.8M 64.4M
Biomarin Pharmaceutical BMRN:US $ 120.8M 178.7M
Cytokinetics CYTK:US $ -89.44M 58.88M
Dynavax Technologies DVAX:US $ 32.86M 66.92M
Enanta Pharmaceuticals ENTA:US $ -33.59M 3.48M
Exelixis EXEL:US $ 68.57M 26.59M
Gilead Sciences GILD:US $ 19M 363M
Halozyme Therapeutics HALO:US $ 60.11M 6.66M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
Intra Cellular Therapies ITCI:US $ -72.12M 13.62M
Nektar Therapeutics NKTR:US $ -90.39M 55.25M
Neurocrine Biosciences NBIX:US $ 13.9M 21.2M
Pfizer PFE:US $ 7863M 4470M
Prothena PRTA:US $ -36.29M 3.11M
Regeneron Pharmaceuticals REGN:US $ 973.5M 1255.5M
Repligen RGEN:US $ 46.96M 17.85M
Rigel Pharmaceuticals RIGL:US $ -27.44M 4.8M
Sarepta Therapeutics SRPT:US $ -105.02M 16.96M
Teva Pharmaceutical TEVA:IT -955000000 797M
Ultragenyx Pharmaceutical RARE:US $ -152.32M 29.86M
Vertex Pharmaceuticals VRTX:US $ 762.1M 8.01M
Xoma XOMA:US $ -2280000 32.12M
YTE INCY:US $ 37.99M 525.86M